Princeton Global Asset Management LLC bought a new position in shares of West Pharmaceutical Services Inc. (NYSE:WST) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 3,525 shares of the medical instruments supplier’s stock, valued at approximately $346,000.
Several other institutional investors also recently made changes to their positions in the company. Intermede Investment Partners Ltd grew its holdings in shares of West Pharmaceutical Services by 5.3% during the fourth quarter. Intermede Investment Partners Ltd now owns 266,471 shares of the medical instruments supplier’s stock valued at $26,122,000 after buying an additional 13,400 shares in the last quarter. Stifel Financial Corp grew its stake in West Pharmaceutical Services by 14.4% in the fourth quarter. Stifel Financial Corp now owns 23,776 shares of the medical instruments supplier’s stock valued at $2,326,000 after purchasing an additional 2,985 shares in the last quarter. Lord Abbett & CO. LLC purchased a new position in West Pharmaceutical Services in the fourth quarter valued at about $12,989,000. Mackenzie Financial Corp purchased a new position in West Pharmaceutical Services in the third quarter valued at about $275,000. Finally, Marshall Wace LLP grew its stake in West Pharmaceutical Services by 614.6% in the third quarter. Marshall Wace LLP now owns 99,369 shares of the medical instruments supplier’s stock valued at $12,269,000 after purchasing an additional 85,464 shares in the last quarter. 94.39% of the stock is currently owned by institutional investors.
Shares of WST traded down $0.12 during trading hours on Friday, hitting $111.52. 379,805 shares of the company were exchanged, compared to its average volume of 368,453. The company has a market cap of $8.22 billion, a PE ratio of 39.69, a price-to-earnings-growth ratio of 3.54 and a beta of 1.25. West Pharmaceutical Services Inc. has a 52 week low of $84.91 and a 52 week high of $125.09. The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.40 and a current ratio of 3.15.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Wednesday, April 17th will be given a dividend of $0.15 per share. The ex-dividend date is Tuesday, April 16th. This represents a $0.60 annualized dividend and a dividend yield of 0.54%. West Pharmaceutical Services’s dividend payout ratio is presently 21.35%.
Separately, Zacks Investment Research upgraded West Pharmaceutical Services from a “sell” rating to a “hold” rating in a research note on Saturday, January 12th.
West Pharmaceutical Services Company Profile
West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.
Featured Story: Net Income
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.